Post-approval studies (Phase 4)UnknownNCT03260556What this trial is testingPirfenidone for Progressive Fibrotic SarcoidosisWho this might be right forSarcoidosis, Pulmonary University of Cincinnati 60
Testing effectiveness (Phase 2)Looking for participantsNCT04467723What this trial is testingCombination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLCWho this might be right forNSCLC Stage IVNSCLC, Recurrent University of Kansas Medical Center 25
Testing effectiveness (Phase 2)UnknownNCT05118256What this trial is testingPirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated SilicosisWho this might be right forSilicosisProgressive Massive FibrosisComplicated Silicosis Instituto de investigación e innovación biomédica de Cádiz 18
Not applicableStudy completedNCT05826821What this trial is testingBiomarkers in HF: Circulating Biomarkers of Fibrosis and Cardiovascular DiseaseWho this might be right forHeart Failure With Preserved Ejection Fraction Manchester University NHS Foundation Trust 107
Testing effectiveness (Phase 2)Study completedNCT02632877What this trial is testingEfficacy of Pirfenidone Plus MODD in Diabetic Foot UlcersWho this might be right forDiabetic Foot Ulcer University of Guadalajara 60
Testing effectiveness (Phase 2)Study completedNCT03099187What this trial is testingPirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung DiseaseWho this might be right forLung Diseases, Interstitial Hoffmann-La Roche 253
Testing effectiveness (Phase 2)UnknownNCT05373914What this trial is testingRESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Blade Therapeutics 200
Not applicableStudy completedNCT03958071What this trial is testingA Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are TakingWho this might be right forIdiopathic Pulmonary Fibrosis Boehringer Ingelheim 13,264
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07161791What this trial is testingCamrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast CancerWho this might be right forBreast CancerTriple Negative Breast Cancer (TNBC) Harbin Medical University 12
Large-scale testing (Phase 3)Study completedNCT00287716What this trial is testingThree-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Genentech, Inc. 435
Not applicableStudy completedNCT03115619What this trial is testingQuality of Life Study in Participants With IPF Under Pirfenidone TreatmentWho this might be right forIdiopathic Pulmonary Fibrosis Hoffmann-La Roche 102
Not applicableStudy completedNCT02622477What this trial is testingClinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)Who this might be right forIdiopathic Pulmonary Fibrosis Hoffmann-La Roche 12
Testing effectiveness (Phase 2)UnknownNCT05542615What this trial is testingProlonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).Who this might be right forLiver CirrhosisHepatitis C, ChronicEpigenetic Disorder University of Guadalajara 60
Large-scale testing (Phase 3)UnknownNCT03857854What this trial is testingEfficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)Who this might be right forDermatomyositis Interstitial Lung Disease (Dm-ILD) Beijing Continent Pharmaceutical Co, Ltd. 152
Early research (Phase 1)Study completedNCT03315741What this trial is testingThe Safety and Tolerability of Pirfenidone for BOS After HCTWho this might be right forBronchiolitis ObliteransGraft Vs Host Disease Stanford University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05350371What this trial is testingSafety and Tolerability of Pirfenidone in Acute PancreatitisWho this might be right forPancreatitis, Acute University of Alabama at Birmingham 60
Early research (Phase 1)Study completedNCT06588517What this trial is testingComparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed ConditionsWho this might be right forIdiopathic Pulmonary Fibrosis Overseas Pharmaceuticals, Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT02707640What this trial is testingAssess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Hoffmann-La Roche 123
Large-scale testing (Phase 3)Study completedNCT00662038What this trial is testingOpen-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Genentech, Inc. 1,058
Testing effectiveness (Phase 2)Study completedNCT04675619What this trial is testingEvaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity PneumonitisWho this might be right forHypersensitivity Pneumonitis Zagazig University 40